ADCT Financials
ADC Therapeutics SA - Financial statements & key metrics
Stock Price
$3.52
Market Cap
$436.05M
EPS
$-1.41
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$70.84M
Gross Profit
$64.89M
Operating Income
$-130.65M
Net Income
$-157.85M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$321.98M
Total Liabilities
$524.62M
Shareholders Equity
$-202.64M
Cash & Equivalents
$250.87M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-123.83M
CapEx
$867000
Free Cash Flow
$-124.70M
Profitability Metrics
Gross Margin
-57.4%
Operating Margin
-1.9%
Net Margin
-2.2%
ROE
-7.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ADCT revenue?
ADCT's most recent quarterly revenue was $70.84M. Annual revenue can be calculated by summing the four most recent quarters.
Is ADCT profitable?
ADCT reported a loss of $157.85M in the most recent quarter. The net profit margin is -2.2%.
What is ADCT market cap?
ADCT has a market capitalization of $436.05M, making it a small-cap stock.
Does ADCT have debt?
View ADCT's balance sheet for debt information.
What is ADCT cash flow?
ADCT's most recent quarterly free cash flow was $-124.70M.